- pause slideshow
There has been negative publicity in the national press about drug manufacturers increasing the price of some medicines significantly: so called ‘price gouging’. These increased prices are then passed on to the NHS, and lead to headlines quoting multi-million pound figures.
Rare but not forgotten: why drug appraisal methods must be updated to consider treatments for rare diseasesSubscription
The UK government needs to adapt its drug and technology appraisal methods to prevent patients with rare diseases being left out in the cold.
As pharmacy contractors in England suffer budget cuts and their leaders instigate legal action, Northern Ireland pharmacy contractor Terry Maguire argues why this might not be a good idea and what English contractors might learn from their Celtic cousins.
Evidence is emerging that biocides and heavy metals all contribute to the growing problem of antimicrobial resistance.
Reclassifying erectile dysfunction drug sildenafil as a pharmacy medicine would not be such a huge leapSubscription
Allowing pharmacists to sell sildenafil would offer men a convenient, safe, and perhaps less intimidating, channel for seeking professional advice and treatment for erectile dysfunction.
We outline some of the issues pharmacists might like to consider before they cast their vote in the UK general election on 8 June 2017.
While the implications of Brexit on drug regulation in the UK are largely unknown, the government needs to consider its options quickly to avoid delaying public access to important medicine.
The new urgent medicine supply scheme from NHS England requires more thought and revision.
After a dwindle in the number of reclassifications of prescription-only to pharmacy medicines in the UK, things are starting to look up, writes Natalie Gauld.
Limiting HIV resistance must not be neglected in an era where we continue to see breakthroughs in treatment for the infection once labelled a death sentence.
Cholesterol-lowering statin therapy for healthy people is not as simple as 'yes' or 'no'Subscription
Recent reports of large trials extolling the virtues of statins have led many to believe that low-risk patients should take them, but an examination of the evidence provides food for thought.
There are a number of factors that contribute to patients’ fear and reluctance to take osteoporosis drugs, leaving them at increased risk of fractures.
NHS cyber attack: views from the front lineSubscription
The Pharmaceutical Journal spoke to pharmacists to find out how the cyber attack of 12 May 2017 affected their service provision and what they did to manage the situation.
Restricting what is allowed on prescription in England: views from healthcare professionals and patient groupsSubscription
We ask healthcare professionals across primary care and patient groups for their thoughts on NHS England’s decision to review what GPs are allowed to prescribe.
Q&A: How to ensure access to essential medicines for those in low and middle-income countriesSubscription
Andy Gray and Hans Hogerzeil, co-chairs of the The Lancet Commission on Essential Medicines, discuss the analysis on the cost of providing essential medicines to people in low and middle-income countries.
Shanelle Hall from UNICEF discusses the breakthrough pentavalent vaccine three-year tender with six vaccine suppliers.
The obesity epidemic. Why diets and exercise don’t work and what does, by Robyn Toomath
Admissions: a life in brain surgery, by Henry Marsh
Why dieting is a battle of the mindSubscription
The hungry brain. Outsmarting the instincts that make us overeat, by Stephan Guyenet
How telomeres affect your health and longevitySubscription
The telomere effect by Elizabeth Blackburn and Elissa Epel
John Betts, keeper of the Royal Pharmaceutical Society (RPS) museum since 2010, speaks to Corrinne Burns about the latest activities of the museum team — including a new app, free to download now from the iTunes store.
The Royal Pharmaceutical Society (RPS) has signed a partnership agreement with the Society of Hospital Pharmacists of Australia, a national professional membership body in Australia representing over 4,500 pharmacists, pharmacy technicians and pharmacists in training working in Australia’s hospitals and other clinical healthcare settings.
Pharmacist independent prescribers can make a significant contribution to antimicrobial stewardshipSubscription
Karen Hodson, member of the Welsh Pharmacy Board, and colleagues discuss their experiences of how pharmacist prescribers can help in antimicrobial stewardship.
It’s RPS national board election time againSubscription
Alex MacKinnon, interim chief executive of the Royal Pharmaceutical Society, makes a plea for members to use their vote in the 2017 national board elections.
From Graham Phillips’s letter about his attendance at the ‘Quality for patients: pharmacy practice now and in the future’ conference (The Pharmaceutical Journal 2017;298:234), I thought he was going to report on the conference but all he offered was a rant at the chief pharmaceutical officer (CPO) for England for, in his view, inadequate ...
Working together to find solutionsSubscription
On 8 May 2017, some local practice forum (LPF) steering group members called upon the candidates in the national pharmacy board elections to recognise the efforts of hundreds of volunteers and publicly support LPFs. Over the past two years I have visited many LPFs and have been ...
Engaging both members and non-membersSubscription
Over the past few weeks, I have been delighted to see a higher level of engagement than has probably been seen in the past. Much of this has been through modern social media routes such as Twitter and Telegram. This is something the Royal Pharmaceutical Society (RPS) should investigate further to see how it utilises these media to maximise the engagement with members and non-members that utilise these media routes. The debate has been challenging and maybe some of it has drifted into ...
So much of the work done by the Royal Pharmaceutical Society (RPS) is positive and I greatly appreciate this, but to retain and grow the membership, we must focus more on the needs and wants of the members. The work around the Faculty is a case in point. Most grassroots members I know can see no current value in joining and building a Faculty portfolio. With the introduction of General Pharmaceutical Council’s (GPhC) revalidation, members will look to the RPS for support.
Julia Robinson reports from a meeting discussing the implications of Brexit on UK pharmacovigilance.
Andrew Haynes explains how the chemical weapon sarin damages the body and eventually kills those exposed to it.
Briony Hudson summarises a lecture about how medicinal plants were used during the wartime in Great Britain.
Undergraduate pharmacy students are learning to engage with telehealth activities to prepare them for their future career.
Thomas Geoffrey Booth (1928-2016)Subscription
Thomas Geoffrey Booth, past president of the Royal Pharmaceutical Society, founded the UK’s first department of pharmacy practice.
Frank P Palopoli (1922–2016) Subscription
The scientist who discovered the fertility drug clomifene was known as a modest man who mentored his staff.
Kirit Patel (1949-2016)Subscription
A self-made man who started out wanting to own a shop to support his family, Kirit Patel’s lifetime achievements are inspirational.
Philip Majerus (1936-2016)Subscription
Majerus was one of the first researchers who discovered the benefits of low dose aspirin in preventing heart attacks and strokes.